Jefferson Alessandro Schmitz Junior
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jefferson Alessandro Schmitz Junior has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Dib Gonçalves
Graduate Program in Animal Science with Emphasis on Bioactive Products, Universidade Paranaense, Umuarama 87502-210, Brazil
2 shared publications - Gabriela Favero Espolador
Universidade Paranaense
2 shared publications - Isabela Carvalho dos Santos
Universidade Paranaense
2 shared publications - Karolaine Bezerra
Programa de Pós-Graduação em Ciência Animal com Ênfase em Produtos Bioativos, Universidade Paranaense – UNIPAR, Umuarama, Brasil
2 shared publications - Lidiane Nunes Barbosa
Universidade Paranaense
2 shared publications - André Felipe Berto De Almada
Universidade Paranaense UNIPAR
1 shared publication
Latest Publications
- Open Access
- 5 December 2022
- Published by Revista Mundi in Revista Mundi Engenharia, Tecnologia e Gestão (ISSN: 2525-4782)
- Vol. 7 (3)
USE OF CURCUMA LONGA L. AS A DRUG: A BIBLIOGRAPHIC ESSAY ABOUT THE MECHANISMS OF THE ACTION OF THE CONSTITUENTS OF THE SPECIES AGAINST PATHOLOGICAL PROCESSES.
In the present work, the objective was to list the activities and mechanisms of action that classify as promising agents in the treatment of pathogenic processes the human species the constituents of the species Curcuma longa L. (or as it is popularly known, turmeric). Taking into account the phytotherapic characteristics of the species, it is suggested to use it as an alternative in the treatment of inflammatory processes caused by biological agents, or even in the treatment of diseases such as cancer and Alzheimer's. The studies addressed show antibacterial, antifungal, antitumor properties, and among others, as being attributed to the species mainly thanks to its main and major phenolic constituent: curcumin. The work was developed from studies in the scientific literature, through research platforms such as academic google and scielo, in addition to the use of books. Thanks to the results obtained, it is possible to classify the plant, which was already commonly used in some pathological processes, as a way to treat diseases and even as cosmetics. It is then suggested the study and development of drugs that address the use of curcumin in its composition, since the biological and chemical activities of this compound are proven to help in the treatment of some pathological processes.
- 5 December 2022
- Published by Revista Mundi in Revista Mundi Engenharia, Tecnologia e Gestão (ISSN: 2525-4782)
- Vol. 7 (3)
Open AccessUSE OF CURCUMA LONGA L. AS A DRUG: A BIBLIOGRAPHIC ESSAY ABOUT THE MECHANISMS OF THE ACTION OF THE CONSTITUENTS OF THE SPECIES AGAINST PATHOLOGICAL PROCESSES.
In the present work, the objective was to list the activities and mechanisms of action that classify as promising agents in the treatment of pathogenic processes the human species the constituents of the species Curcuma longa L. (or as it is popularly known, turmeric). Taking into account the phytotherapic characteristics of the species, it is suggested to use it as an alternative in the treatment of inflammatory processes caused by biological agents, or even in the treatment of diseases such as cancer and Alzheimer's. The studies addressed show antibacterial, antifungal, antitumor properties, and among others, as being attributed to the species mainly thanks to its main and major phenolic constituent: curcumin. The work was developed from studies in the scientific literature, through research platforms such as academic google and scielo, in addition to the use of books. Thanks to the results obtained, it is possible to classify the plant, which was already commonly used in some pathological processes, as a way to treat diseases and even as cosmetics. It is then suggested the study and development of drugs that address the use of curcumin in its composition, since the biological and chemical activities of this compound are proven to help in the treatment of some pathological processes.
- Open Access
- 27 September 2022
- Published by Universidade Paranaense in Arquivos de Ciências da Saúde da UNIPAR
- Vol. 26 (3)
ORIGANUM VULGARE ESSENTIAL OIL AND CARVACROL: NATURAL ALTERNATIVES AGAINST RESISTANT BACTERIA
Bacteria that are resistant to several antibiotics are a serious One Health problem, as new alternatives for treatment do not appear at the same speed. Thus, the aim of this work was to carry out a survey of studies involving the activity of the essential oil of O. vulgare and its isolated compound carvacrol on antibiotic-resistant bacteria. To this end, a qualitative review of the literature was carried out in the PubMed database from 2015 to 2020. Both for the essential oil and for the isolated compound, the inhibitory action extends to strains often associated with difficult-to-treat infections such as oxacillin and vancomycin-resistant Staphylococcus aureus, ?-lactamase-producing strains, carbapenemases, among others. The point that distinguishes the studies is the type of methodology used in the tests, with studies with carvacrol more directed towards mechanisms of molecular action and application in cells and animals, while those with oils are more preliminary. Although these substances have potential to control resistant bacteria, more research is needed to enable their use.
- 27 September 2022
- Published by Universidade Paranaense in Arquivos de Ciências da Saúde da UNIPAR
- Vol. 26 (3)
Open AccessORIGANUM VULGARE ESSENTIAL OIL AND CARVACROL: NATURAL ALTERNATIVES AGAINST RESISTANT BACTERIA
Bacteria that are resistant to several antibiotics are a serious One Health problem, as new alternatives for treatment do not appear at the same speed. Thus, the aim of this work was to carry out a survey of studies involving the activity of the essential oil of O. vulgare and its isolated compound carvacrol on antibiotic-resistant bacteria. To this end, a qualitative review of the literature was carried out in the PubMed database from 2015 to 2020. Both for the essential oil and for the isolated compound, the inhibitory action extends to strains often associated with difficult-to-treat infections such as oxacillin and vancomycin-resistant Staphylococcus aureus, ?-lactamase-producing strains, carbapenemases, among others. The point that distinguishes the studies is the type of methodology used in the tests, with studies with carvacrol more directed towards mechanisms of molecular action and application in cells and animals, while those with oils are more preliminary. Although these substances have potential to control resistant bacteria, more research is needed to enable their use.
- Open Access
- 17 September 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (10)
Bacteriophages’ action against mastitis-causing bactéria
Mastitis is a breast tissue disease with a high incidence in dairy cows and implications ranging from the health of the animals to the economy of the sector. Although antibiotic therapy is widely used, the search for new perspectives in the management and treatment of this disease is necessary. Although phage research preceded the discovery of antibiotics, with the appearance of antibiotics and their efficiency in treating infections, phage therapy fell into disuse. However, phage therapy has now re-emerged as an alternative for combating multidrug-resistant bacteria. The relationship between phages, bacteria, and the immune system is unique, generating a wide range of opportunities, some of which have yet to be studied. Thus, the objective of this review was to analyze the use of bacteriophages in the control of bovine mastitis and its association with other natural products today. Phages have been shown to exert effective antibacterial and anti-biofilm activity, and their interactions with other substances of natural origin could be a viable path for treating disease. Despite being little explored, phages are already being considered as an alternative for treatment against the main bacterial agents of mastitis. In this review, the safety and future pathways of phage therapy are addressed in order to indicate points where research still needs to progress and the main advantages and difficulties in this area.
- 17 September 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (10)
Open AccessBacteriophages’ action against mastitis-causing bactéria
Mastitis is a breast tissue disease with a high incidence in dairy cows and implications ranging from the health of the animals to the economy of the sector. Although antibiotic therapy is widely used, the search for new perspectives in the management and treatment of this disease is necessary. Although phage research preceded the discovery of antibiotics, with the appearance of antibiotics and their efficiency in treating infections, phage therapy fell into disuse. However, phage therapy has now re-emerged as an alternative for combating multidrug-resistant bacteria. The relationship between phages, bacteria, and the immune system is unique, generating a wide range of opportunities, some of which have yet to be studied. Thus, the objective of this review was to analyze the use of bacteriophages in the control of bovine mastitis and its association with other natural products today. Phages have been shown to exert effective antibacterial and anti-biofilm activity, and their interactions with other substances of natural origin could be a viable path for treating disease. Despite being little explored, phages are already being considered as an alternative for treatment against the main bacterial agents of mastitis. In this review, the safety and future pathways of phage therapy are addressed in order to indicate points where research still needs to progress and the main advantages and difficulties in this area.